The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BTOG 2024 | Ongoing trials in thoracic radiotherapy: evaluating current role and significance
Clive Peedell, MD, James Cook University Hospital in Middlesbrough, UK, discusses ongoing important trials in thoracic radiotherapy, primarily in North America, and ongoing prophylactic cranial irradiation (PCI) trials internationally, emphasizing the significance of these studies in evaluating the current role of radiotherapy. He stresses the importance of not overlooking the role of radiotherapy in the palliative setting, particularly for patients with symptomatic disease who may benefit from single fraction radiotherapy, such as 8 Gy. This interview took place at the BTOG 2024 congress in Belfast, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
